What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Cancer
His primary areas of study are Immunology, Molecular biology, Antigen, Receptor and Cell biology.
Immunoglobulin E, Atopic dermatitis, Langerhans cell, Immune system and Atopy are the primary areas of interest in his Immunology study.
His Molecular biology research is multidisciplinary, incorporating perspectives in Cell culture, T cell, Dendritic cell, MHC class I and CD3.
His study looks at the intersection of Antigen and topics like Epidermis with Pathology, Keratinocyte, Cytotoxic T cell, Thymocyte and Hairless.
His study in the fields of Degranulation under the domain of Receptor overlaps with other disciplines such as Response Evaluation Criteria in Solid Tumors.
His Cell biology research is multidisciplinary, incorporating elements of Histiocyte, CCL21, CC chemokine receptors and Antigen-presenting cell.
His most cited work include:
- Immunologic Functions of Ia-Bearing Epidermal Langerhans Cells (629 citations)
- Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). (558 citations)
- Epidermal Langerhans cells bear Fc and C3 receptors. (490 citations)
What are the main themes of his work throughout his whole career to date?
Georg Stingl focuses on Immunology, Molecular biology, Pathology, Cell biology and Antigen.
As part of his studies on Immunology, Georg Stingl often connects relevant areas like Receptor.
Georg Stingl combines subjects such as Langerhans cell, Cell culture, Dendritic cell, T-cell receptor and Epidermis with his study of Molecular biology.
The various areas that Georg Stingl examines in his Langerhans cell study include Monoclonal antibody and CD1.
His Immunoglobulin E research integrates issues from Autoantibody and Allergy.
His studies in T cell integrate themes in fields like Cytotoxic T cell, MHC class I and CD8.
He most often published in these fields:
- Immunology (43.87%)
- Molecular biology (16.98%)
- Pathology (13.92%)
What were the highlights of his more recent work (between 2012-2021)?
- Immunology (43.87%)
- Dermatology (11.79%)
- Pathology (13.92%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Immunology, Dermatology, Pathology, Atopic dermatitis and Psoriasis.
Innate lymphoid cell, Immunoglobulin E, Bullous pemphigoid, Inflammation and Allergy are subfields of Immunology in which his conducts study.
His Inflammation study combines topics from a wide range of disciplines, such as Dendritic cell, Cell biology and Monocyte.
Georg Stingl has researched Dermatology in several fields, including Ustekinumab and Internal medicine, Disease, Dermatitis herpetiformis.
His work carried out in the field of Pathology brings together such families of science as Immunofluorescence, Compartment and Immune system.
His Atopic dermatitis research includes elements of Sensitive skin and Pimecrolimus.
Between 2012 and 2021, his most popular works were:
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis (432 citations)
- Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder. (163 citations)
- Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis. (106 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Cancer
Georg Stingl spends much of his time researching Immunology, Psoriasis, Dermatology, Atopic dermatitis and Disease.
Georg Stingl studies Food allergy which is a part of Immunology.
His study on Psoriasis also encompasses disciplines like
- Tumor necrosis factor alpha that intertwine with fields like CCL20, Molecular biology, CD11c, Dendritic cell and Myeloid,
- Cytokine and related Keratinocyte, CXCL1, Antibody and CCL7.
The study incorporates disciplines such as High dose intravenous immunoglobulin, Internal medicine, Evidence-based medicine and Ustekinumab in addition to Dermatology.
His Atopic dermatitis study integrates concerns from other disciplines, such as Odds ratio, Incidence, Pimecrolimus, Asthma and Sensitive skin.
His studies deal with areas such as Immunofluorescence, Anti-nuclear antibody and Immune system as well as Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
